FDA Inspection 1264613 - Mayinglong Pharmaceutical Group Co Ltd - March 14, 2025

Record Details

This FDA Inspection record concerns Mayinglong Pharmaceutical Group Co Ltd, with an inspection on March 14, 2025, issued by the Office of Inspections and Investigations, covering human drugs.

Company: Mayinglong Pharmaceutical Group Co Ltd
Inspection Date: March 14, 2025
Product Type: Human Drugs
Office: Office of Inspections and Investigations

Open in Dashboard

ID · 1ad73c7c-df72-408e-a5c5-66c29048c1d6

Violation Codes1

21 CFR 211.166(b)

Full citation text and observation details available on the Dashboard.